{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:38:38Z","timestamp":1789983518809,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12877-018-1015-9","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T11:17:22Z","timestamp":1546946242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Consensus and evidence-based medication review to optimize and potentially reduce psychotropic drug prescription in institutionalized dementia patients"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-5167","authenticated-orcid":false,"given":"Mireia","family":"Massot Mesquida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Tristany Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Franzi Sis\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Garc\u00eda Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Hern\u00e1ndez Vian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-7427","authenticated-orcid":false,"given":"Pere","family":"Tor\u00e1n Monserrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"1015_CR1","volume-title":"A national clinical guideline","author":"Scottish Intercollegiate Guidelines Network","year":"2006","unstructured":"Scottish Intercollegiate Guidelines Network. Management of patients with dementia. In: A national clinical guideline; 2006."},{"key":"1015_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/gps.1858","volume":"23","author":"M Steinberg","year":"2008","unstructured":"Steinberg M, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County study. Int J Geriatr Psychiatry. 2008;23:170\u20137.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1015_CR3","doi-asserted-by":"publisher","first-page":"e1566","DOI":"10.1136\/bmj.e1566","volume":"344","author":"S Bergh","year":"2012","unstructured":"Bergh S, Selbaek G, Engedal K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomized, parallel group, placebo controlled trial. BMJ. 2012;344:e1566.","journal-title":"BMJ"},{"issue":"4","key":"1015_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0210-4806(10)70045-0","volume":"38","author":"JM Garc\u00eda-Alberca","year":"2010","unstructured":"Garc\u00eda-Alberca JM, Lara Mu\u00f1oz P, Berthier Torres M. Neuropsychiatric and behavioral symptomatology in Alzheimer disease. Actas Esp Psiquiatr. 2010;38(4):212\u201322.","journal-title":"Actas Esp Psiquiatr"},{"issue":"3","key":"1015_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1017\/S1041610298005365","volume":"10","author":"R McShane","year":"1998","unstructured":"McShane R, Gedling K, Keene J, et al. Getting lost in dementia: a longitudinal study of a behavioral symptom. Int Psychogeriatr. 1998;10(3):253\u201360.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"1015_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.regg.2009.10.002","volume":"45","author":"J G\u00f3mez-Pav\u00f3n","year":"2010","unstructured":"G\u00f3mez-Pav\u00f3n J, Gonz\u00e1lez Garc\u00eda P, Franc\u00e9s Rom\u00e1n I, et al. Recomendaciones en la prevenci\u00f3n de reacciones adversas a medicamentos en personas mayores con demencia. Rev Esp Geriatr Gerontol. 2010;45(2):89\u201396.","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"1015_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2050-6511-14-10","volume":"14","author":"M Gustafsson","year":"2013","unstructured":"Gustafsson M, Karlsson S, L\u00f6vheim H. Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharcology and Toxicology. 2013;14:10.","journal-title":"BMC Pharcology and Toxicology"},{"key":"1015_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2050-6511-14-56","volume":"14","author":"M Gustafsson","year":"2013","unstructured":"Gustafsson M, Karlsson S, L\u00f6vheim H. Psychotropic drug use among people with dementia \u2013 a six-month follow-up study. BMC Pharcology and Toxicology. 2013;14:56.","journal-title":"BMC Pharcology and Toxicology"},{"key":"1015_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/hup.1160","volume":"26","author":"M Azermai","year":"2011","unstructured":"Azermai M, Elseviers M, Petrovic M, Van Bortel L, Vander Stichele R. Geriatric drug utilization of psychotropics in Belgian nursing homes. Hum Psychopharmacol Clin Exp. 2011;26:12\u201320.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"1015_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/gps.1349","volume":"20","author":"M Gobert","year":"2005","unstructured":"Gobert M, D\u2019hoore W. Prevalence of psychotropic drug use un nursing homes for the aged in Quebec and in French-speaking area of Switzerland. Int J Geriatr Psychiatry. 2005;20:712\u201321.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1015_CR11","doi-asserted-by":"publisher","first-page":"e6231","DOI":"10.1136\/bmj.e6231","volume":"345","author":"S Billioti de Gage","year":"2012","unstructured":"Billioti de Gage S, B\u00e9gaud B, Bazin F, Verdoux H, Dartigues JF, P\u00e9r\u00e8s K, Kurth T, Pariente A. Benzodiazepine use and risk of dementia: prospective population-based study. BMJ. 2012;345:e6231.","journal-title":"BMJ"},{"key":"1015_CR12","volume-title":"The use of antipsychotic medication for people with dementia: time for action. A report for the minister of state for care services","author":"S Banerjee","year":"2009","unstructured":"Banerjee S. The use of antipsychotic medication for people with dementia: time for action. A report for the minister of state for care services. London: Department of Health; 2009."},{"issue":"5","key":"1015_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2040622316658463","volume":"7","author":"RR Tampi","year":"2016","unstructured":"Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis. 2016;7(5):229\u201345.","journal-title":"Ther Adv Chronic Dis"},{"key":"1015_CR14","volume-title":"Madrid: Ministerio de Sanidad, Pol\u00edtica Social e Igualdad","author":"Estudio EARCAS","year":"2011","unstructured":"Estudio EARCAS. Eventos Adversos en Residencias geri\u00e1tricas y centros Asistenciales Sociosanitarios. In: Madrid: Ministerio de Sanidad, Pol\u00edtica Social e Igualdad; 2011."},{"key":"1015_CR15","doi-asserted-by":"publisher","first-page":"d4551","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551.","journal-title":"BMJ"},{"key":"1015_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","volume":"8","author":"C Ballard","year":"2009","unstructured":"Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Edmund Juszczak E, Yu LM, Jacoby R. For the DART-AD investigators. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8:151\u20137.","journal-title":"Lancet Neurol"},{"key":"1015_CR17","doi-asserted-by":"publisher","first-page":"g6420","DOI":"10.1136\/bmj.g6420","volume":"349","author":"A Corbett","year":"2014","unstructured":"Corbett A, Burns A, Ballard C. Don\u2019t use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ. 2014;349:g6420. \n                    https:\/\/doi.org\/10.1136\/bmj.g6420\n                    \n                  .","journal-title":"BMJ"},{"key":"1015_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1745-6215-13-85","volume":"13","author":"KH Pitkala","year":"2012","unstructured":"Pitkala KH, Juola AL, Soini H, Laakkonen ML, Kautiainen T-G, Finne-Soveri H, Bjorkman M. Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial. Trials. 2012;13:85.","journal-title":"Trials"},{"key":"1015_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1745-6215-14-13","volume":"14","author":"R Whitaker","year":"2013","unstructured":"Whitaker R, Ballard C, Stanfford J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Knapp M, Woodward Carlton B, Fossey J. Feasibility study of an optimized person-centered intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomized controlled trial. Trials. 2013;14:13.","journal-title":"Trials"},{"key":"1015_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13012-015-0268-3","volume":"10","author":"C Richter","year":"2015","unstructured":"Richter C, berg A, Fleischer S, K\u00f6pke S, Balzer K, Fick EM, S\u00f6nnichsen A, L\u00f6scher S, Vollmar HC, Haastert B, Icks A, Dintsios CM, Mann E, Wolf U, Meyer G. Effect of person-centered care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial. Implement Sci. 2015;10:82.","journal-title":"Implement Sci"},{"key":"1015_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1471-244X-13-280","volume":"13","author":"C Smeets","year":"2013","unstructured":"Smeets C, Smalbrugge M, Gerritsen DL, Nelissen-Vrancken M, Wetzels RB, van der Speck K, Zuidema SU, Koopmans R. Improving psychotropic drug prescription in nursing home patients with dementia: desing of a cluster randomized controlled trial. BMC Psychiatry. 2013;13:280.","journal-title":"BMC Psychiatry"},{"key":"1015_CR22","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC index. \n                    https:\/\/www.whocc.no\/atc_ddd_index\n                    \n                  \/ . Accesed 31 July 2018."},{"key":"1015_CR23","unstructured":"American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Patien-centered Care for older adults with Multiple Chronic Conditions: A Stepwise Approach from the American geriatrics Society. J Am Geriatr Soc 2012. Special article. 1\u201312."},{"issue":"2","key":"1015_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methds. 2007;39(2):175\u201391.","journal-title":"Behavior Research Methds"},{"key":"1015_CR25","doi-asserted-by":"publisher","unstructured":"Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R. Effect of enhanced psychological care on antipsychotic use in nursing home residents with severe dementia: cluster randomized trial. BMJ. 2006. \n                    https:\/\/doi.org\/10.1136\/bmj.38782.575868.7C\n                    \n                  .","DOI":"10.1136\/bmj.38782.575868.7C"},{"key":"1015_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/ageing\/afy001","volume":"47","author":"K Spek Van der","year":"2018","unstructured":"Van der Spek K, Koopmans R, Smalbrugge M, Nelissen-Vrancken M, Wetzels R, Smeets C, Vries E, Teerenstra S, Zuidema SU, Geritsen DL. The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomized controlled trial. Age Ageing. 2018;47:430\u20137.","journal-title":"Age Ageing"},{"key":"1015_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1532-5415.2009.02617.x","volume":"58","author":"SM Patterson","year":"2010","unstructured":"Patterson SM, Hughes C, Crealey G, Cardwell C, Lapane KL. An evaluation of an adapted US model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc. 2010;58:44\u201353.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"1015_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5694\/mja17.00857","volume":"208","author":"JL Westbury","year":"2018","unstructured":"Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, Bindoff A, Peterson GM. RedUSe; reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208(9):398\u2013403.","journal-title":"Med J Aust"},{"key":"1015_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40266-015-0266-9","volume":"32","author":"JS Buckley","year":"2015","unstructured":"Buckley JS, Salpeter SR. A risk-benefit assessment of dementia medications: systematic review of the evidence. Drugs Aging. 2015;32:453\u201367.","journal-title":"Drugs Aging"},{"issue":"12","key":"1015_CR30","first-page":"618","volume":"59","author":"DB Hogan","year":"2014","unstructured":"Hogan DB, Strafford B. Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease. CanJPsychiatry. 2014;59(12):618\u201323.","journal-title":"CanJPsychiatry"},{"key":"1015_CR31","doi-asserted-by":"publisher","first-page":"e1566","DOI":"10.1136\/bmj.e1566","volume":"344","author":"S Bergh","year":"2012","unstructured":"Bergh S, Selb\u00e6k G, Engedal K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial. BMJ. 2012;344:e1566. \n                    https:\/\/doi.org\/10.1136\/bmj.e1566\n                    \n                  .","journal-title":"BMJ"},{"key":"1015_CR32","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1056\/NEJMoa1114058","volume":"367","author":"DP Devanand","year":"2012","unstructured":"Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B. Relapse risk after discontinuation of risperidone in Alzheimer\u2019s disease. N Engl J Med. 2012;367:1497\u2013507.","journal-title":"N Engl J Med"},{"issue":"22","key":"1015_CR33","first-page":"147","volume":"2","author":"M Massot","year":"2016","unstructured":"Massot M, Tristany M, Franzi A, Garcia I. Reducing the number of antidepressants, antipsychotics and benzodiazepines in nursing home residents with dementia. European Journal of General Practice. 2016;2(22):147\u201354.","journal-title":"European Journal of General Practice"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-1015-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12877-018-1015-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-018-1015-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T19:08:27Z","timestamp":1578424107000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-018-1015-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1186\/s12877-018-1015-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study protocol was approved by the Ethics and Clinical Research Committee of the Jordi Gol Primary Care Research Institute (IDIAPJGol, Fundaci\u00f3 Institut Universitari per a la recerca a l'Atenci\u00f3 Prim\u00e0ria de salut Gol i Gurina) of the Catalan Health Institute (ICS, Institut Catal\u00e0 de la Salut, Code: P15\/120). The IDIAPJGol supervises all primary care research activity within the ICS. General Practitioners who participated in the implementation of the intervention were members of the research team and verbally consent their participation. Informed consent for participation was not required from the patients, as the intervention was focused on the prescribing doctors, not on the patients, themselves.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"7"}}